MUC2 and ovarian carcinoma: To our knowledge, this study is the first to investigate the actual immunomodulatory effect of the MUC2 molecules secreted by ovarian cancer cells based on a molecular pathology approach, which provided new insight into the relationship between cancer cells and TAMs.